The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

Baeten D, De Keyser F, Mielants H, Veys EM (2002) Ankylosing spondylitis and bowel disease. B Pract Res Clin Rheumatol 16:537–549

Smale S, Natt RS, Orchard TR, Russel AS, Bjarnason I (2001) Inflammatory bowel disease and spondyloarthropathy. Arthritis Rheum 44:2728–2736

Gravallese EM, Kantrowitz FG (1988) Arthritic manifestations of inflammatory bowel disease. Am J Gastroenterol 83:703–709

Schorr-Lesnick B, Brandt LJ (1988) Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol 83:216–223

Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136:896–907

Kidd BI, Cawley MI (1988) Delay in diagnosis of spondylarthritis. Br J Rheumatol 27:230–232

Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF et al (1997) A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a community wide epidemiologic study. Has the classic case misled us? Arch Intern Med 157:2111–2117

Spoorenberg A, van der Hejde D, de Klerk E, Dougados M, de Vlam K, Mielents H et al (1999) Relative values of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984

Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M et al (2001) Musculoskeletal manifestation in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313

de Vlam K, Mielants H, Cuvelier C, de Keyser F, Veys EM, de Vos M (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860–2865

Palm O, Moum B, Ongre A, Gran JT (2002) Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (The IBSEN Study). J Rheumatol 29:511–515

Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122

Gul A, Uyar FA, Inanc M, Ocal L, Barrett JH, Aral H et al (2002) A weak association of HLA-B*2702 with Behcet’s disease. Genes Immun 3:368–372

Houman H, Ben Dahmen F, Ben Ghorbel I, Chouaib S, Lamloum M, Kchir N et al (2001) Behcet’s disease associated with Crohn’s disease. Ann Med Interne (Paris) 152:480–482

Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218–1227

van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

International Study Group for Behçet’s Disease: criteria for diagnosis of Behçet’s disease (1990) Lancet 335:1078–1080

Steer S, Jones H, Hibbert J, Kondeatis E, Vaughan R, Sanderson J et al (2003) Low back pain, sacroiliitis, and the relation with HLA-B27 in Crohn’s disease. J Rheumatol 30:518–522

Scarpa R, Del Puente A, D’Arienzo A, di Girolamo C, della Valle G, Panarese A (1992) The arthritis of ulcerative colitis: clinical and genetical aspects. J Rheumatol 19:373–377

Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391

Scott WW, Fishman EK, Kuhlman JE, Caskey CI, O’Brien JJ, Walia GS et al (1990) Computed tomography evaluation of the sacroiliac joints in Crohn’s disease. Radiologic/clinical correlation. Skeleton Radiol 19:207–210

Queri R, Maiz O, Intxausti J, de Dios JR, Belzunegui J, Gonzalez C et al (2000) Subclinic sacroiliitis in inflammatory bowel disease: a clinical and follow-up study. Clin Rheumatol 19:445–449

McEniff N, Eustace S, McCharthy C, O’Malley M, O’Morain CA, Hamilton S (1995) Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography. Clin Imaging 19:258–262

Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K (1994) High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum 37:23–31

Mielants H, De Vos M, Cuvelier C, Veys EM (1996) The role of gut inflammation in the pathogenesis of spondyloarthropathies. Acta Clin Belg 51:340–349

Torok HP, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H et al (2004) Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion 70:49–54

Picco P, Gattorno M, Vignola S, Barabino A, Marazzi MG, Bondi E et al (1999) Clinical and biological characteristics of immunopathological disease-related erythema nodosum in children. Scand J Rheumatol 28:27–32

Gordon LK, Eggene M, Holland GN, Weisz JM, Braun J (1998) pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol 18:264–271

Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapoglu E et al (2004) HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers 20:309–312

Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C (2004) HLA class I and II genotyping in patients with Behcet’s disease: a regional study of eastern part of Turkey. Tissue Antigens 64:293–297